Stay updated on Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab and sunitinib in advanced thymic cancer is now displayed, including its study details and participating locations. The study is listed as active but no longer recruiting.
    Difference
    55%
    Check dated 2026-11-08T02:25:41.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T22:26:59.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and links to updates and FAQs, noting that NIH content may use both “Super Intelligence” and “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T22:29:02.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-17T22:33:22.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The displayed site revision advances from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:05.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a standard header and footer, replacing the expected study record content. This indicates restricted access to the requested resource.
    Difference
    0.5%
    Check dated 2026-09-26T22:04:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Sunitinib in Thymic Cancer Clinical Trial page.